Interferon-alpha induced sarcoidosis with cutaneous involvement along the lines of venous drainage

Annals of Dermatology

Volumn 23, Issue 2, 2011, Pages 239-241

  Lee, Young Bok ^a   Lee, Jae In ^a   Park, Hyun Jeong ^a   Cho, Baik Kee ^a   Oh, Shin Taek ^a,b  

^a The Catholic University of Korea   (South Korea)

^b Daejeon St Mary's Hospital   (South Korea)

Author keywords

Hepatitis c; Interferon alpha; Intraveous drug user; Sarcoidosis; Scar

Indexed keywords

EID: 79958696988     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2011.23.2.239     Document Type: Article

References (16)

1. lannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-2165.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-755.
3. Hurst EA, Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol 2005;141:865-868. (Pubitemid 41058068)
4. Faurie P, Broussolle C, Zoulim F, Trepo C, Sève P. Sarcoidosis and hepatitis C: clinical description of 11 cases. Eur J Gastroenterol Hepatol 2010;22:967-972.
5. Leclerc S, Myers RP, Moussalli J, Herson S, Poynard T, Benveniste O. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med 2003;14:237-243. (Pubitemid 36952702)
6. Akahoshi M, Ishihara M, Remus N, Uno K, Miyake K, Hirota T, et al. Association between IFNA genotype and the risk of sarcoidosis. Hum Genet 2004;114:503-509. (Pubitemid 38678930)
7. Ramos-Casals M, Mañá J, Nardi N, Brito-Zerón P, Xaubet A, Sánchez-Tapias JM, et al. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore) 2005;84:69-80. (Pubitemid 40418635)
8. Doyle MK, Berggren R, Magnus JH. Interferon-induced sarcoidosis. J Clin Rheumatol 2006;12:241-248. (Pubitemid 44527044)
9. Goldberg HJ, Fiedler D, Webb A, Jagirdar J, Hoyumpa AM, Peters J. Sarcoidosis after treatment with interferon-alpha: a case series and review of the literature. Respir Med 2006; 100:2063-2068. (Pubitemid 44514945)
10. Shuja F, Kavoussi SC, Mir MR, Jogi RP, Rosen T. Interferon induced sarcoidosis with cutaneous involvement along lines of venous drainage in a former intravenous drug user. Dermatol Online J 2009; 15:4.
11. Zampino MR, Corazza M, Borghi A, Marzola A, Virgili A. HLA typing in an IFN-alpha-induced scar sarcoidosis: possible pathogenetic and clinical implications. Acta Derm Venereol 2009;89:661-662.
12. Ramos-Casals M, Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol 2005;17:447-455. (Pubitemid 41058405)
13. Fantini F, Padalino C, Gualdi G, Monari P, Giannetti A. Cutaneous lesions as initial signs of interferon alpha-induced sarcoidosis: report of three new cases and review of the literature. Dermatol Ther 2009;22(Suppl. 1):S1-S7.
14. Pietinalho A, Ohmichi M, Hirasawa M, Hiraga Y, Lofroos AB, Selroos O. Familial sarcoidosis in Finland and Hokkaido, Japan-a comparative study. Respir Med 1999;93:408-412. (Pubitemid 29265351)
15. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, lannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-241.
16. Martinetti M, Luisetti M, Cuccia M. HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:83-95. (Pubitemid 34685906)